PWCM
TMO icon

Processus Wealth & Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Processus Wealth & Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.96M Sell
5,906
-641
-10% -$308K 1.75% 21
2026
Q1 		$3.22M Buy
6,547
+12
+0.2% +$6.51K 2.19% 20
2025
Q4 		$3.79M Sell
6,535
-16
-0.2% -$9.05K 2.5% 19
2025
Q3 		$3.18M Buy
6,551
+264
+4% +$123K 2.28% 20
2025
Q2 		$2.55M Buy
6,287
+180
+3% +$75.3K 2.01% 22
2025
Q1 		$3.04M Buy
6,107
+134
+2% +$72.6K 2.59% 15
2024
Q4 		$3.11M Buy
5,973
+68
+1% +$37.4K 2.48% 16
2024
Q3 		$3.65M Sell
5,905
-156
-3% -$92.3K 3.01% 11
2024
Q2 		$3.35M Buy
6,061
+107
+2% +$61.3K 2.78% 15
2024
Q1 		$3.46M Buy
5,954
+956
+19% +$536K 3.07% 12
2023
Q4 		$2.65M Buy
+4,998
New +$2.42M 2.65% 13

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Processus Wealth & Capital Management's TMO Position: Q2 2026 in Review

Processus Wealth & Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 9.8% in Q2 2026, selling an estimated $308K and leaving 5,906 shares worth $2.96M. The position accounts for 1.75% of the portfolio, ranked #21.

Processus Wealth & Capital Management first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.79M in Q4 2025. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Processus Wealth & Capital Management held 5,906 shares of Thermo Fisher Scientific worth $2.96M as of Q2 2026.
  • Processus Wealth & Capital Management sold 641 Thermo Fisher Scientific shares in Q2 2026, an estimated $308K.
  • Thermo Fisher Scientific made up 1.75% of Processus Wealth & Capital Management's portfolio in Q2 2026, its #21 holding.
  • Processus Wealth & Capital Management first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
  • Processus Wealth & Capital Management's Thermo Fisher Scientific position peaked at $3.79M in Q4 2025.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Processus Wealth & Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.